Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.
By D. Sturm, H. Witt, V. Hovestadt, Dong-Anh Khuong-Quang, David T. W. Jones, Carolin Konermann, E. Pfaff, M. Tönjes, M. Sill, S. Bender and 68 more. Cancer Cell, 2012
1,735 citations recorded by the source corpus.
Subfields: Cancer Research, Genetics
View Paper: https://www.semanticscholar.org/paper/d545dc096e786e2828043275f35d8640ddcd99b8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Gad Getz
- Eric S. Lander
- Matthew Meyerson
- Aviv Regev
- Christopher Sander
- R. Jenkins
- Peter W. Laird
- David Haussler
In Genetics
- Michael Weller
- M. Wiznerowicz
- Patrycja Czerwińska
- Guido Reifenberger
- Jill S. Barnholtz-Sloan
- Zhuowen Tu
- Aviv Regev
- Christopher Sander
Citations in the corpus
- DNA methylation-based classification of central nervous system tumours (2018, positive): “Subsets of the reference cohort have been previously published 4,9–16 , 26– 33 .”
- Similarity network fusion for aggregating data types on a genomic scale (2014, background): “05×10−4) to be associated with Subtype 3 [14, 8].”
- Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion (2015, neutral): “…thalamic HGGs typically occurring inmid-childhood, cortical gliomas of childhood occurring in older children and young adults, and HGG of later adulthood occurring chiefly in the frontotemporal lobes (Khuong-Quang et al., 2012; Schwartzentruber et al., 2012; Sturm et al., 2012; Wu et al., 2012).”
- Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma (2017, background): “520), as reported previously (Sturm et al., 2012); however it was also found to be significantly elevated in PXA-like tumors (median beta value 0.”
- Glioma Subclassifications and Their Clinical Significance (2017, background): “3 appear mostly in pericallosal GBMs in adolescent and young adults aged 9–42 years [35].”
- Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation (2018, methodology): “Additionally, we downloaded independent, non-TCGA datasets of gliomas [(Sturm et al., 2012) (GSE36245, GSE36278) and (Turcan et al.”
- Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma (2013, neutral): “Three experienced neuropathologists agreed on pilocytic astrocytoma histology for this case, although a diagnosis of GBM cannot be conclusively excluded, owing to limited material.”
- The Somatic Genomic Landscape of Glioblastoma (2013, background): “reported that adult and pediatric GBM with alterations of IDH1, H3F3A, and receptor tyrosine kinases (RTK)were associatedwith epigenetic subtypes (Sturm et al., 2012).”
- High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2014, background): “Prognosis of mixed anaplastic oligoastrocytoma and anaplastic astrocytoma is intermediate between GBM and pure anaplastic oligodendroglioma.”
- Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3 (2013, background): “(24) reported that a small subset of PN GBM (after removing IDH1 mutant samples) has a worse prognosis.”